Elsevier

Neuropharmacology

Volume 36, Issues 11–12, November–December 1997, Pages 1665-1678
Neuropharmacology

Normalization of cytochrome-c oxidase activity in the rat brain by neuroleptics after chronic treatment with PCP or methamphetamine

https://doi.org/10.1016/S0028-3908(97)00152-4Get rights and content

Abstract

Previous studies, primarily involving the use of positron emission tomography (PET), have contributed to the hypothesis that a state of hypometabolism may underlie schizophrenia. The chronic use of methamphetamine (MAP) or phencyclidine (PCP), both of which have been shown to enhance dopaminergic function in the brain, leads to a psychotic state in man which has prompted the suggestion that these compounds may have utility as models of schizophrenia. In the present study, regional alterations in energy metabolism were examined in the rat brain using cytochrome-c oxidase (COX) and succinate dehydrogenase (SDH) histochemistry following chronic treatment with PCP and MAP. PCP and MAP were administered alone or in the presence of fluphenazine or clozapine to animals for 28 days, after which mitochondrial enzyme activities were estimated. Both PCP and MAP produced profoundly similar decreases in COX activity in a broad spectrum of regions. Most prominent in this regard were the caudate-putamen, nucleus accumbens and septum. No changes were noted in sections stained for SDH activity, suggesting that results were dependent upon neither a generalized mitochondrial dysfunction nor mitochondrial loss. Cell counts and TUNEL histochemistry also failed to reveal any significant differences between control and treated animals, implying that reductions were not a result of cell loss. Both clozapine and fluphenazine offered varying degrees of protection from the effects of PCP and MAP. The results provide evidence which implicates dopaminergic hyperactivity in the finding of reduced energy metabolism in the brains of schizophrenics.

References (53)

  • F.R. Sharp et al.

    Phencyclidine induction of the hsp70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels

    Neuroscience

    (1994)
  • P. Sokoloff et al.

    Novel dopamine receptors half a decade later

    Trends in Pharmacological Sciences

    (1995)
  • F.X. Vollenweider et al.

    Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

    European Neuropsychopharmacology

    (1997)
  • G.C. Wagner et al.

    Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

    Brain Research

    (1980)
  • L.T. Weiss-Wunder et al.

    Heterogeneous distribution of cytochrome oxidase activity in the rat substantia nigra: correlation with tyrosine hydroxylase and dynorphin immunoreactivities

    Brain Research

    (1990)
  • M. Wong-Riley

    Changes in the visual system of monocularly sutured or enucleated cats demonstrable with cytochrome oxidase histochemistry

    Brain Research

    (1979)
  • M. Wong-Riley

    Cytochrome oxidase: an endogenous metabolic marker for neuronal activity

    Trends in Neurosciences

    (1989)
  • A. Breler et al.

    Schizophrenia is accoiated with elevated amphetamineinduced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

  • M.S. Buchsbaum et al.

    Fontostriatal disorder of cerbral metabolism in never-medicated schizophrenics

    Archives of General Psychiatry

    (1992)
  • L. Cavalier et al.

    Decreased cytochrome-c oxidase activity and lack of age related accumulation of mtDNA in the brains of schizophrenics

    Genomics

    (1995)
  • J.R. Cooper et al.

    The Biochemical Basis of Neuropharmacology

  • E.H. Ellinwood et al.

    Chronic stimulant intoxication models in schizophrenia

  • G. Ellison et al.

    Long-term changes in dopaminergic innervation of caudate nucelus after continuous amphetamine administration

    Science

    (1978)
  • G. Ellison et al.

    Dissimilar patterns of degeneration in brain following four different addictive stimulants

    Neuroreport

    (1993)
  • G. Ellison

    Stimulant-induced psychosis, the dopamine theory of schizophrenia, and the habenula

    Brain Research Reviews

    (1994)
  • X.-M. Gao et al.

    Delayed regional metabolic actions of phencyclidine

    European Journal of Pharmacology

    (1993)
  • Cited by (31)

    • Parkin-deficient rats are resistant to neurotoxicity of chronic high-dose methamphetamine

      2021, Experimental Neurology
      Citation Excerpt :

      Interestingly, chronic self-administration of ~1.5 mg/kg/d METH lead to decreased levels of some complex I subunits (NDUFS1, NDUFV1) and increases in others (NUFS5) within rats striatal synaptosomes at 14 days after the last operant session; no changes in complex II subunits were detected (Bosch et al., 2015). Price and colleagues observed no change in complex II activity and decreased complex IV activity in the striatum after 28 days of chronic treatment with 5 mg/kg METH (Prince et al., 1997). The data suggests that changes in the levels of ETC enzyme subunits are time-, species-, and METH-dose dependent.

    • Mitochondrial impairment, apoptosis and autophagy in a rat brain as immediate and long-term effects of perinatal phencyclidine treatment - influence of restraint stress

      2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry
      Citation Excerpt :

      Deficits in mitochondrial respiratory chain complexes (Maurer et al., 2001) and reduced numbers and volume of mitochondria have been identified in the cortex and other brain regions of schizophrenia patients (Kung and Roberts, 1999; Uranova et al., 2001). There is accumulating evidence that a reduction of COX activity in the frontal cortex contributes to schizophrenia pathogenesis (Prince et al., 1997a,b). A reduction of COX activity was observed in the frontal cortex and caudate nuclei in schizophrenic vs. control brain tissue (Cavelier et al., 1995).

    • Schizophrenia: Maternal inheritance and heteroplasmy of mtDNA mutations

      2012, Molecular Genetics and Metabolism
      Citation Excerpt :

      Methamphetamine, which induces psychosis in normal individuals, reduced COX activity and conversely, treatment with neuroleptic agents such as clozapine and fluphenazine increased this enzyme activity in the frontal cortex of rat brains. Moreover, the methamphetamine-induced reduction of COX activity is prevented by the use of neuroleptic agents [14, 15]. Furthermore, there is a relationship between the accumulation of mtDNA deletions in an individual cell and a reduction of COX activity, and these deletions increase with aging in normal individuals [16].

    • Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia

      2011, International Journal of Developmental Neuroscience
      Citation Excerpt :

      For example, SZ patients showed large reductions in cytochrome-c oxidase activity in the caudate nucleus, the frontal cortex and the temporal cortex (Cavelier et al., 1995; Maurer et al., 2001). Rodent studies suggest that this reduction is not caused by treatment (Prince et al., 1997a,b). In the PFC of BPD patients, complex I activity was impaired and associated with increased protein oxidation and nitration (Andreazza et al., 2010).

    View all citing articles on Scopus
    View full text